Kiran Dhillon
Advancing Vaccines to Prevent & Treat Cancer & Importance of Diversity in Clinical Trials
From top left to bottom right: Dr. Raymonda Johnson, Dr. Kiran Dhillon, Glorianne Jackson, Marilyn Lacy, Dr. Shaveta Vinayak, Dr. Nora...
top of page
Cancer Vaccine Institute Blog
Kiran Dhillon
- Oct 17, 2022
CVI highlighted at W Day event with UW Volunteer Leaders!
Dr. Nora Disis, CVI Director, and Dr. Nicole Kretzer, Clinical Acting Instructor, spoke this past Friday, October 14th as part of...
-
- Feb 28, 2022
2021 Year in Review Newsletter!
In 2021, our Cancer Vaccine Institute team worked relentlessly toward our efforts to ignite the immune system to end cancer. To learn...
-
- Nov 29, 2021
A Champion for Cancer Patients from Underserved Communities
When Bridgette Hempstead was diagnosed with breast cancer at age 35, she realized that there were very few resources available for black...
-
- Sep 22, 2021
New CVI paper on a Phase I/II clinical trial with on combination of Pembrolizumab with low dose carb
Ovarian cancer is a deadly disease that affects one in 78 women. While therapies that activate the immune system have been effective in...
Blog: Blog2
bottom of page